TAMPA, Fla. – Moffitt Cancer Center will host its seventh-annual Business of Biotech conference from 8 a.m. to 1:30 p.m. Feb. 11 in the Vincent A. Stabile Research Building, 12902 Magnolia Drive. This year’s theme is “Partnering for Success.”
“We are delighted that Bob Ingram, general partner with Hatteras Venture Partners, will be featured as the keynote speaker this year,” said conference chairman Jarett Rieger, director of the Office of Technology Management and Commercialization and associate general counsel. “He will provide his insights on successfully attracting capital from venture capital firms and Big Pharma.” Ingram, the chair for the CEO Roundtable on Cancer, received the Martin Luther King, Jr. Legacy Award for International Service in 2004.
Since the inaugural conference in 2006, the conference has brought together the best and brightest from biomedical companies, startups, research organizations, service providers, entrepreneurs and investors for networking and partnership discussions.
Breakout sessions will focus on:
- Tissue Regeneration and Repair: Importance of Tissue in Medicine
- Tales on the Road to Capital Raising
- Cyber Security Healthcare
- Personalized Medicine: Next Generation of Healthcare
Tampa Mayor Bob Buckhorn will be honored prior to the keynote address with the Moffitt Momentum Award. The award was created to honor public servants whose tireless efforts are instrumental in the fight against cancer in Florida.
Partners for the conference include BioFlorida, Enterprise Florida, Florida Medical Manufacturers Consortium, Pinellas County Economic Development, Tampa Bay Partnership, Tampa Bay Innovation Center, Southeastern Medical Device Association, The Greater Tampa Chamber of Commerce, Florida High Tech Corridor, Personalized Medicine Coalition, and the Tampa Hillsborough Economic Development Corporation. The event is free, but reservations are required because seating is limited. To register, call 1-888-MOFFITT (1-888-663-3488).
About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Since 1999, Moffitt has been listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. With more than 4,200 employees, Moffitt has an economic impact on the state of nearly $2 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on Facebook, twitter and YouTube.